Guggenheim has earned $172 million from advising Pfizer on nearly $400 billion in acquisitions since 2011. Pfizer’s stock ...
Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.
3don MSN
Gregory Francfort, Guggenheim Securities lead restaurant analyst, joins CNBC's 'The Exchange' to discuss the economic impact ...
On Tuesday, Verastem Inc (VSTM) stock saw a modest uptick, ending the day at $3.13 which represents a slight increase of $0.13 or 4.33% from the prior close of $3. The stock opened at $2.98 and ...
They noted that NFLX shares are up 56% year-to-date compared to 22% for the benchmark S&P index, and continue to see ...
Colorado’s premier conservative training course, has announced their 2025 participants. The list includes prominent activists ...
On Monday, Deckers Outdoor Corp (DECK) stock saw a decline, ending the day at $160.73 which represents a decrease of $-0.52 or -0.32% from the prior close of $161.25. The stock opened at $161.99 and ...
While both high yield bonds and leveraged loans offer value, investors should prioritize quality, focusing on higher rated issuers and maintaining senior positions in the capital structure. In the ...
The Solomon R. Guggenheim Museum, known for its distinctive architectural design and contemporary art collections, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback